A randomized, open-label, active-controlled, multicenter, parallel group study to assess the efficacy, safety and tolerability of topical 10 % terbinafine hydrogen chloride (HCI) formulation versus 5% amorolfine nail lacquer for 48 weeks of treatment in patients wiht mild to moderate toenail onychomycosis
Laufzeit: 01.01.2007 - 31.12.2008
imported
Kurzfassung
After the screening period, eligible patients will be randomly assigned to either 10% terinafine HCI NSO or 5% amorolfine nail lacquer in a 1:1 ratio. The study medication will be applied every day for a total of 48 weeks.
